Targeting regulatory T cells with heterodimeric proteins

    公开(公告)号:US10519242B2

    公开(公告)日:2019-12-31

    申请号:US14214475

    申请日:2014-03-14

    Applicant: Xencor, Inc.

    Abstract: The present invention provides methods and compositions comprising a heterodimeric antibody comprising a first monomer comprising a first variant heavy chain constant region and an anti-CD4 binding moiety. The heterodimeric antibody also comprises a second monomer comprising: a second variant heavy chain constant region and an anti-CD25 binding moiety. In some cases, the pIs of the first and second variant heavy chain constant regions are at least 0.5 logs apart.

    TRISPECIFIC ANTIBODIES
    45.
    发明申请

    公开(公告)号:US20190352416A1

    公开(公告)日:2019-11-21

    申请号:US16530946

    申请日:2019-08-02

    Applicant: Xencor, Inc.

    Abstract: Provided herein are trispecific antibodies that include a) a first monomer, b) a second monomer, and c) a light chain. The first monomer includes a first variant Fc domain and a variable heavy domain, the second monomer includes a second variant Fc domain and a first scFv domain and the light chain includes a variable light domain. The variable heavy domain and the variable light domain form an antigen binding domain. The trispecific antibody further includes a second scFv domain on either the first or second monomers.

Patent Agency Ranking